2010
DOI: 10.1556/oh.2010.29017
|View full text |Cite
|
Sign up to set email alerts
|

Breast conserving oncoplastic surgery in the treatment of centrally located malignant breast tumors

Abstract: Central breast neoplasms account for 5 to 20% of breast cancer cases. For decades, they have been traditionally treated with mastectomy. The high incidence of involvement associated with these tumors necessitates nipple and areola resection. Oncoplastic surgical techniques, in well selected cases, enable the achievement of adequate cosmetic results following a radical central quadrantectomy along with the Nipple-Areola Complex. The present paper summarizes the indications, techniques and results of breast cons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…This is a breast cancer with one of the worst biological behaviours. Its clinical appearance is explained by tumour invasion of the lymphatic vessels of the skin (breast swelling, marked oedema, erythema, peau d’orange), which mimics an inflammatory disease (T4d) ( 21 ).…”
Section: Surgical Treatment Of Non-invasive Tumours (Carcinoma ...mentioning
confidence: 99%
See 2 more Smart Citations
“…This is a breast cancer with one of the worst biological behaviours. Its clinical appearance is explained by tumour invasion of the lymphatic vessels of the skin (breast swelling, marked oedema, erythema, peau d’orange), which mimics an inflammatory disease (T4d) ( 21 ).…”
Section: Surgical Treatment Of Non-invasive Tumours (Carcinoma ...mentioning
confidence: 99%
“…Gene testing can only be performed in accordance with strict professional standards in accredited laboratories. BRCA1/2 mutation carriers or other mutations holders with high penetrant genes (see above) should also be informed and various therapeutic options (such as close follow-up, oncopsychological guidance, lifestyle counselling, family screening, reproductive counselling, chemoprevention, and prophylactic mastectomy) should be discussed only in specialized centres with adequate knowledge and experience ( 21 ). During genetic testing, BRCA mutations are most commonly examined; however, if these are not present and if there is significant family history, other less common genetic disorders should also be considered (Li-Fraumeni syndrome: p53 mutation; Cowden’s syndrome: PTEN mutation; ATM mutation; Lynch-syndrome: MLH1 , MSH2 , MSH6 , EPCAM , PMS2 mutation, RAD51 mutation, BRIP1 mutation, PALB2 mutation, CHEK2 mutation, Peutz-Jeghers syndrome: STK11 mutation, CDH1 mutation).…”
Section: Surgical Treatment Of Non-invasive Tumours (Carcinoma ...mentioning
confidence: 99%
See 1 more Smart Citation